No Detail Found!

Omicron's spike protein Mutations and vaccine Efficacy: Understanding the impact and future Strategies in combating sars-cov-2 Variants: review

Author(s)
Tooba Ashiq Seyal Bioscience Department, Comsats University, Islamabad, Pakistan
Maham Fatima Ashiq Clinical Medicine, North Sichuan Medical College (NSME),,China
Ammar Ali Khan Abbottabad International Medical College, Abbottabad, AIMC, Pakistan
Talha Ashiq sayal Coventry, University London, Coventry,
Muhammad Ahsan Ashiq Abbottabad International Medical College, Abbottabad, AIMC, Pakistan
Sahir Hameed Khattak Oilseeds Research Program, Crop Sciences Institute, National Agricultural Research Centre, Islamabad, Pakistan
Sania Begum National Institute for Genomics & Advanced Biotechnology, NARC, Islamabad, Pakistan
Farkhanda Jabeen National Institute for Genomics & Advanced Biotechnology, NARC, Islamabad, Pakistan
Farhana Amin National Institute for Genomics & Advanced Biotechnology, NARC, Islamabad, Pakistan
Aliya Errum Abbottabad International Medical College, Abbottabad, AIMC, Islamabad, Pakistan
Tahira Kamal National Institute for Genomics & Advanced Biotechnology, NARC, Islamabad, Pakistan
Rabia Ikram National Institute for Genomics & Advanced Biotechnology, NARC, Islamabad, Pakistan
Muhammad Aqeel Aslam Oilseeds Research Program, Crop Sciences Institute, National Agricultural Research Centre, Islamabad, Pakistan
Saida Komal National Institute for Genomics & Advanced Biotechnology, NARC Islamabad, Pakistan; Department of Agronomy, University of Poonch, Rawlakot, Pakistan
Anum Farrukh Fauji Foundation Hospital Rawalpindi, Pakistan
Sadia Noor Hussain Allama Iqbal Memorial Teaching Hospital Sialkot, Pakistan
Imadad Kaleem Bioscience Department, Comsats University, Islamabad, Pakistan
Ghulam Muhammad Ali Bioscience Department, Comsats University, Islamabad
Abstract
Omicron Spike protein has a notably high number of mutations. These mutations are related to the unique characteristics of the SARS-CoV-2 Omicron Virus The symptoms of Covid-19 reported up till now are fever, cough, sore throat, Shortness of breath or chest pain, headache, nausea or fatigue, stuffy or runny nose, sore eyes, loss of smell or taste, muscle pain, sneezing, reduced appetite and abdominal pain. In some studies Omicron shows considerably but not a complete escape from Pfizer r BNT162b2 Vaccine in which they engineered lungs cell line. Pfizer-BioNTech booster post data was compared there was a drop of vaccine efficacy was seen from 96.5% against delta to 80.1% against omicron Pfizer-BioNTech booster dose is going to be very effective to alleviate the future effects of omicron virus in different countries. However in near future Omicron variant specific vaccines are much needed in current situation the risk of new variant can be reduced by vaccinating a large number of people to limit the space of virus. If efficacy of vaccine is partial, it still protects people from getting sick. The vaccine works by boosting immune system on sensing any SARS-CoV-2 virus. It may be said that the future of SARS-CoV-2 is still in hands of human. By vaccinating more people, changes in virus that cause a new variant to emerge can be stop. According to Rambaut, virus has multiple directions in which it can go.
Publication Details
Page(s) 711-718
DOI DOI not available
Published Journal: International Journal of Biology and Biotechnology, Volume: 22, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Vaccination, SARS-CoV-2 Omicron Virus, Cell line, Prevention from disease, organs.
References
Baghchechi M.,Jaipaul N.,Jacob S. E. .2020 .The rise and evolution of COVID-19. International Journal of Women's Dermatology, 6(4) : 248-254.
Cai Y.,Zhang J.,Lavine C. L.,Rawson S.,Peng H.,Zhu H.,Anand K.,Tong P.,Gautam A.,Lu S.,Sterling S. M.,Walsh R. M.,Rits-Volloch J.,Lu D. R.,Wesemann W.,Yang M. S.,Seaman B.,Chen B. .2021 .Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. , 373 : 642-648.
Callaway E. .2021 .Heavily mutated coronavirus variant puts scientists on alert. Nature, 25 : .
Cele S.,Jackson L,Khoury D. S.,Khan K.,Moyo-Gwete T.,Tegally H.,San J. E.,Scheepers C.,Amoako D.,Karim F.,Bernstein M.,Lustig G.,Archary D.,Smith M.,Ganga Y.,Jule Z.,Reedoy K.,Hwa S. H.,Sigal A .2021 .Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature, 602 : 654-656.
Chowell S.,Blumberg L.,Simonsen M. A.,Miller C.,Viboud C. .2014 .Synthesizing data and models for the spread of MERS-CoV, 2013: key role of index cases and hospital transmission. Epidemics, 9 : 40-51.
Omicron- ,-Sars-Cov- ,- .2021 .Classification-of-. B.1.1, : .
Del Rio C.,Omer S. B.,Malani P. N. .2021 .Winter of Omicron-The Evolving COVID-19 Pandemic. , 327(4) : 319-320.
Diamond M.,Halfmann P.,Maemura T.,Iwatsuki-Horimoto K.,Iida S.,Simon V. .2021 .529 Omicron virus causes attenuated infection and disease in mice and hamsters. The SARS-CoV-2 B. 1.1, 603(7902) : 687-692.
Du X.,Tang H.,Gao L.,Wu Z.,Meng F.,Qin F. .2022 .Omicron adopts a different strategy from Delta and other variants to adapt to host. Signal transduction and targeted therapy, 7(1) : 1-3.
Forni D.,Cagliani R.,Clerici M.,Sironi M. .2017 .Molecular evolution of human coronavirus genomes. Trends in Microbiology, 25(1) : 35-48.
Gobeil S. M.,Janowska K.,McDowell S.,Mansouri K.,Parks R.,Stalls V.,Kopp M. F.,Manne K.,Li D.,Wiehe K.,Saunders K. O.,Edwards R. J.,Korber B.,Henderson B. F. Haynes R.,Acharya P. .2021 .Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity. Science, 373 : eabi6226.
Halfmann S.,Iida K.,Iwatsuki-Horimoto T.,Maemura M.,Kiso S. M.,Scheaffer T. L.,Darling A.,Joshi S.,Loeber G.,Singh S. L.,Foster B.,Ying J. B.,Case Z.,Chong B.,Whitener J.,Moliva K.,Floyd M.,Ujie Y.,Kawaoka Y. .2022 .SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature, 603 : 687-692.
Hogan S. L.,Wu P.,Doohan O. J.,Watson P.,Winskill A. C.,Ghani A. C. .2021 .Report 48- The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variant. , : 1-38.
Jamil K.,Khattak S. H.,Farrukh A.,Begum S.,Riaz M. N.,Muhammad A.,Kamal T.,Taj T.,Riaz S.,Batool S. .2022 .Biogenic Synthesis of Silver Nanoparticles Using Catharanthus roseus and Its Cytotoxicity Effect on Vero Cell Lines. Molecules, 27(19) : 6191.
Li W.,Chen Y.,Prévost J.,Lu M.,Gong S. Y.,Tauzin A.,Gasser R.,Vézina D.,Anand S. P.,Goyette G.,Chaterjee D.,Ding S.,Tolbert W. D.,Grunst M. W.,Bo Y.,Zhang S.,Zhou F.,Huang R. K.,Esser L.,Zeher A.,Côté M.,Kumar P.,Sodroski J.,Xia D.,Uchil P. D.,Pazgier M.,Finzi A.,Mothes W. .2022 .Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern. Cell Rep, 38 : 110210.
Ma .2021 .Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells. Cell Discov, 7 : .
Mallapaty S. .2021 .After the WHO report: what's next in the search for COVID's origins. Nature, 592(7854) : 337-338.
Marshall M. .2022 .How can we end the pandemic?. , 4079(22) : 00081-1.
Maslo C.,Friedland R.,Toubkin M.,Laubscher A.,Akaloo T.,Kama B. .2021 .Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves. JAMA, 10(6) : 583-584.
Maurya R.,Swaminathan A.,Shamim U.,Arora S.,Mishra P.,A P.,Pandey R. .2023 .Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition. Iscience, 26(12) : 1-18.
Meng B.,Abdullahi A.,Ferreira I. A. T. M.,Goonawardane N.,Saito A.,Kimura I.,Yamasoba D.,Gerber P. P.,Fatihi S.,Rathore S.,Zepeda S. K.,Kemp S. A.,Ikeda T.,Toyoda M.,Tan T. S.,Kuramochi J.,Mitsunaga S.,R. K. Gupta S. .2022 .Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature, 603(7902) : 706-714.
Mossman K. .2021 .Omicron may not be last variant, but could signal shift in pandemic. CBC News., : .
Plotkin S. A. .2010 .Correlates of protection induced by vaccination. Clinical and Vaccine Immunology, 17(7) : 1055-1065.
Saito A.,Irie T.,Suzuki R.,Maemura T.,Nasser H.,Sato K. .2022 .Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature, 602(7896) : 300-306.
Sette A,Crotty S. .2021 .Adaptive immunity to SARS-CoV-2. , 184(4) : 861-880.
Sharma A.,Lal S. K. .2017 .Zika virus: transmission, detection, control, and prevention. , 8 : 110.
To K. K.,Hung I. F.,Chan J. F.,Yuen K. Y. .2013 .From SARS coronavirus to novel animal and human coronaviruses. Journal of thoracic disease,, 5(Suppl 2) : S103.
Van Blargan L. A.,Errico J. M.,Halfmann P. J.,Zost S. J.,Crowe J. E.,Purcell L. A.,Kawaoka Y.,Corti D.,Fremont D. H.,Diamond M. S. .2022 .An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies. Nature Medicine, 28 : 490-495.
Wei C.,K. J. Shan W.,Wang S.,Zhang Q.,Huan W.,Qian W. .2021 .Evidence for a mouse origin of the SARSCoV-2 Omicron variant. Journal of Genetics and Genomics, 48(12) : 1111-1121.
Wertheim J. O.,Chu D. K.,Peiris J. S.,Pond S. L. Kosakovsky,Poon L. L. .2013 .A case for the ancient origin of coronaviruses. Journal of Virology, 87(12) : 7039-7045.
Woitowich N. C.,Beery A.,Woodruff T. K. .2020 .Opinion: Inclusion of female participants in clinical research. Science, 368(6497) : 1380-1381.
Zhou P.,Yang X. L.,Wang X. G.,Hu B.,Zhang L.,W. L.,Si H.,Zhu Y.,Li B.,Huang C.,Chen H.,Chen J.,Luo Y.,Guo H.,Jiang R.,Chen Y.,Shen X-R.,Wang X.,Zheng X.,Zhao K.,Chen Q.,Deng F.,Yan B.,Zhan F.,Wang Y.,Xiao G.,Shi Z. L. .2020 .A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798) : 270-273.
0

Citations

0

Downloads

48

Views